Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP232443.RAd97QXDgZumadS43AZJZ2IhFepwfEL8iy9AnWsL5uKP8130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232443.RAd97QXDgZumadS43AZJZ2IhFepwfEL8iy9AnWsL5uKP8130_provenance.
• NP625286.RAVdx84w8VDU6Bqf7w7C1XLfzeFa2p0zK5uY_icgqXXTE130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625286.RAVdx84w8VDU6Bqf7w7C1XLfzeFa2p0zK5uY_icgqXXTE130_provenance.
• NP625515.RAbRk5gSTsAugcfm3qbeWrQ9PY9zbe8O3dH2mIvLhccvo130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625515.RAbRk5gSTsAugcfm3qbeWrQ9PY9zbe8O3dH2mIvLhccvo130_provenance.
• NP621847.RAetX6jCCY0t9Dvsv8v8oLVa4KqhGexYfw8gO3UwLsNT8130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621847.RAetX6jCCY0t9Dvsv8v8oLVa4KqhGexYfw8gO3UwLsNT8130_provenance.
• NP623060.RAbFyekAt3D-NDC4Y3UjuxBGn4erarNlyPda4E9ZJuhE8130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623060.RAbFyekAt3D-NDC4Y3UjuxBGn4erarNlyPda4E9ZJuhE8130_provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1128123.RAQTxqrm82r0pugTKcHleNsItuGHyyM0pUbnZpCRZulnc130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128123.RAQTxqrm82r0pugTKcHleNsItuGHyyM0pUbnZpCRZulnc130_provenance.
• NP1128120.RAuSA3nz_2QEE0FQgA7q5ZUeXiur71v62XPCyTItqYwjE130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128120.RAuSA3nz_2QEE0FQgA7q5ZUeXiur71v62XPCyTItqYwjE130_provenance.
• NP232679.RAy6tPhWW0Or3kqBsKqEhUQcu5cDlPmDyHo6Ek_yXtrqU130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232679.RAy6tPhWW0Or3kqBsKqEhUQcu5cDlPmDyHo6Ek_yXtrqU130_provenance.
• NP621545.RANIMdvxrYz1v_kTeNA5FxlDMT-1ZggTd-mfAk94RQ8Wo130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621545.RANIMdvxrYz1v_kTeNA5FxlDMT-1ZggTd-mfAk94RQ8Wo130_provenance.
• NP624146.RAPfj5sDnKMa7Zf4VMPAAcKWKQBo95IvgCQ-znFmD1x7w130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624146.RAPfj5sDnKMa7Zf4VMPAAcKWKQBo95IvgCQ-znFmD1x7w130_provenance.
• NP622829.RAw1lyiIYu5UsEDwN2PumnzCF9mcpnW_tAgDsPhI0KeC8130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622829.RAw1lyiIYu5UsEDwN2PumnzCF9mcpnW_tAgDsPhI0KeC8130_provenance.
• NP624375.RA2mPZZ_2-AalcSnrH5Xtak_m0rKsGsfLR2646mLOxJlg130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624375.RA2mPZZ_2-AalcSnrH5Xtak_m0rKsGsfLR2646mLOxJlg130_provenance.
• NP1128115.RAEziRU5JTwlJ6Q4f_7dxNjN0j65TIpodA7I0D_xOrOpU130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128115.RAEziRU5JTwlJ6Q4f_7dxNjN0j65TIpodA7I0D_xOrOpU130_provenance.
• NP1128116.RAIEV9ZgiMvMP-PCSPj6-s8ICKOWWgHEpiM-aKcNByWkU130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128116.RAIEV9ZgiMvMP-PCSPj6-s8ICKOWWgHEpiM-aKcNByWkU130_provenance.
• NP1128121.RAGqtaX0QhcclBWhrKzlfI71f0SUt3LrtW0rOKLwAszL4130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128121.RAGqtaX0QhcclBWhrKzlfI71f0SUt3LrtW0rOKLwAszL4130_provenance.
• NP1128117.RA9SxYrg6z2Jom7ExQsVMC-Rv9tqYJjq7A5OofpQoOan0130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128117.RA9SxYrg6z2Jom7ExQsVMC-Rv9tqYJjq7A5OofpQoOan0130_provenance.
• NP1128118.RA9VK-xJ3YlDK8kmBNrWmxwUN39EVfOCx7tadDM0td9s0130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128118.RA9VK-xJ3YlDK8kmBNrWmxwUN39EVfOCx7tadDM0td9s0130_provenance.
• NP1128119.RA1LckkR4evF9dFWsQwC0KQQkKErcLoGtVNy7agJf0FB8130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128119.RA1LckkR4evF9dFWsQwC0KQQkKErcLoGtVNy7agJf0FB8130_provenance.
• NP1128122.RA1II8DPLXOSWr2wuuuwkIxPnD3Ujr56vV5fXRBLp7k3U130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128122.RA1II8DPLXOSWr2wuuuwkIxPnD3Ujr56vV5fXRBLp7k3U130_provenance.
• NP1128124.RA1NL0erUOKpO09LEmUbPTywxcpkqu7Pjpx-fCgECXbsQ130_assertion description "[PI3K/AKT/mTOR pathway alterations are frequent in patients with infiltrating breast cancer (IBC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1128124.RA1NL0erUOKpO09LEmUbPTywxcpkqu7Pjpx-fCgECXbsQ130_provenance.